Amyotrophic Lateral Sclerosis, often known as Lou Gehrig's disease, is a progressive and fatal neurodegenerative disorder that affects nerve cells in the brain and spinal cord.

TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a company focused on unlocking the pharmaceutical potential of ...

Amyotrophic Lateral Sclerosis, often known as Lou Gehrig’s disease, is a progressive and fatal neurodegenerative disorder that affects nerve cells in the brain and spinal cord. ALS leads to the ...

The global amyotrophic lateral sclerosis treatment market is undergoing gradual yet impactful transformation, driven by advancements in neurodegenerative disease research, gene-targeted therapies, and ...

People with amyotrophic lateral sclerosis living near harmful algal blooms die almost a year earlier than those who do not. #medindia #neurotoxins #watercontamination’ ...

ALS, short for amyotrophic lateral sclerosis, is a degenerative neurological disorder where the symptoms worsen over time, according to the National Institutes of Health.

Corcept Therapeutics Therapy Fails Primary Goal But Extends Patient Survival In Amyotrophic Lateral Sclerosis Study Vandana Singh Thu, Jun 5, 2025, 11:20 AM3 min read ...

Corcept Therapeutics Therapy Fails Primary Goal But Extends Patient Survival In Amyotrophic Lateral Sclerosis Study by Vandana Singh Benzinga Editor Follow ...

DAZALS is a randomized, double-blind, placebo-controlled Phase 2 study in which 249 patients with ALS were randomized to receive either 150 mg of dazucorilant, 300 mg of dazucorilant or placebo ...

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive neurological disorder that affects motor neurons in the brain and spinal cord.

Wenyan Li, Jinqi Liu and Wenting Li et al. Patient-derived induced pluripotent stem cell organoids for amyotrophic lateral sclerosis drug discovery. Acta Materia Medica. 2025. Vol. 3 (4):556-570.